LEADER 01323nam  2200373Ia 450 
001 9910696939203321
005 20230902161722.0
035   $a(CKB)5470000002383501
035   $a(OCoLC)554771606
035   $a(EXLCZ)995470000002383501
100   $a20100315d1997      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eextended release oral dosage forms, development, evaluation, and application of in vitro/in vivo correlations
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.,$d[1997]
215   $a1 electronic resource (i, 24 pages)
300   $a"BP 2."
300   $a"September 1997."
320   $aIncludes bibliographical references (page 20).
517   $aGuidance for industry 
606   $aDrugs$xDosage forms$zUnited States
606   $aDrug development$zUnited States
615  0$aDrugs$xDosage forms
615  0$aDrug development
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696939203321
996   $aGuidance for industry$93434577
997   $aUNINA